High potency of lipid conjugated TLR7 agonist requires nanoparticulate or liposomal formulation. (2018)
Attributed to:
Nanostructured Polymeric Materials for Healthcare
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ejps.2018.07.048
PubMed Identifier: 30048801
Publication URI: http://europepmc.org/abstract/MED/30048801
Type: Journal Article/Review
Volume: 123
Parent Publication: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
ISSN: 0928-0987